Announcements
15 September 2026
Cancers | Highly Cited Papers Related to Prostate Cancer
We are delighted to share some highly cited papers on prostate cancer published in 2026 in Cancers (ISSN 2072-6694).
The list of highly cited papers can be viewed below:
“Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate Cancer”
by Bicky Thapa, Jacopo Venturini, Atish D. Choudhury and Edoardo Francini
Cancers 2026, 18(11), 1702; https://doi.org/10.3390/cancers18111702
“Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions”
by Maria Chiara Sighinolfi, Giuseppe Pallotta, Marzia Del Re, Koosha Moosavi, Or Schubert, Francesco Rossi, Filippo Gavi, Simone Assumma, Enrico Panio, Angelo Totaro et al.
Cancers 2026, 18(5), 800; https://doi.org/10.3390/cancers18050800
“Chemotherapy-Forward Management of Advanced Prostate Cancer: Taxane Timing, Sequencing and the Real-World Place of Immunotherapy”
by Takahide Noro, Takanobu Utsumi, Rino Ikeda, Naoki Ishitsuka, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Takatoshi Somoto, Ryo Oka, Takumi Endo et al.
Cancers 2026, 18(4), 648; https://doi.org/10.3390/cancers18040648
“Immunotherapeutic Strategies for Prostate Cancer: A Comprehensive Review”
by Ana K. Flores-Islas, Cecilia Rico-Fuentes, Erick Sierra-Díaz, Mariel García-Chagollán, Ana Laura Pereira-Suárez, José Sergio Zepeda-Nuño, José M. Moreno-Ortiz and Adrián Ramírez-de-Arellano
Cancers 2026, 18(2), 255; https://doi.org/10.3390/cancers18020255
“Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation”
by Joanna Robaczyńska, Maciej Maj, Adam Kiljańczyk, Bartosz Pastuszek, Emilia Reducha, Aleksandra Nurkiewicz and Milena Kiljańczyk
Cancers 2026, 18(3), 389; https://doi.org/10.3390/cancers18030389
“Bioactive Natural Products Targeting Androgen Receptor Signaling in Prostate Cancer: A Systematic Review”
by Febby Pratama, Dhania Novitasari, Richa Mardianingrum, Holis Abdul Holik, Nur Kusaira Khairul Ikram and Muchtaridi Muchtaridi
Cancers 2026, 18(5), 786; https://doi.org/10.3390/cancers18050786
“Microbial Genomic Consortia in Prostate Cancer: Mechanistic Signaling, the Gut–Prostate Axis, and Translational Perspectives”
by Eduardo Pérez-Campos Mayoral, Laura Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Hector Alejandro Cabrera-Fuentes, Efrén Emmanuel Jarquín-González, Héctor Martínez-Ruiz, Margarito Martínez-Cruz, Carlos Romero-Diaz, Miriam Emily Avendaño-Villegas, Gabriel Mayoral-Andrade et al.
Cancers 2026, 18(8), 1219; https://doi.org/10.3390/cancers18081219
“NF-κB Signaling in Prostate Cancer Progression: Inflammatory Mediators, Survival Pathways, and Regulatory Axes”
by Ranyah Al-Hakm, Alaa Muayad Altaie, Anania Boghossian, Riyad Bendardaf, Iman M. Talaat and Rifat Hamoudi
Cancers 2026, 18(8), 1227; https://doi.org/10.3390/cancers18081227
“Early Postoperative Outcomes with the Toumai® Surgical System for Robot-Assisted Radical Prostatectomy: A Prospective Comparative Study with da Vinci®”
by Bernardo Rocco, Simona Presutti, Antonio Silvestri, Giuseppe Pallotta, Pierluigi Russo, Sara Mastrovito, Simone Assumma, Filippo Maria Turri, Enrico Panio, Francesco Rossi et al.
Cancers 2026, 18(9), 1321; https://doi.org/10.3390/cancers18091321
“Focal Therapy for Prostate Cancer: State of the Art, Physical Principles, Potentials, and Challenges”
by Luca Orecchia, Simone Steffani, Andrea Micillo, Roberto Miano, Eric Walser and Guglielmo Manenti
Cancers 2026, 18(10), 1523; https://doi.org/10.3390/cancers18101523
The list of relevant Special Issues can be viewed below:
|
“Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer” Guest Editor: Dr. Takanobu Utsumi Submission deadline: 30 November 2026
|
“Advances in the Diagnosis and Treatment of Prostate Cancer: From Biomarkers to Precision Surgery” Guest Editors: Dr. Stamatios N. Katsimperis and Dr. Lazaros Tzelves Submission deadline: 30 November 2026
|
You are welcome to submit relevant papers to Cancers.
Cancers Editorial Office
